Brain disorder classification on PPMI
98.6AccuracySCOPE-PD
Evaluation results
| Method | Links | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| SCOPE-PDData=Subjective and Objective measurements (baseline visits)2026.04 | 98.6 | — | — | — | — | — | — | — | |
| Adebimpe et al.Data=Subjective (UPDRS, MoCA)2026.04 | 93 | — | — | — | — | — | — | — | |
| PatchTSTProtocol=Five-fold cross-validation, Runs=52026.02 | 91.89 | 83.52 | 85.24 | 84.05 | 90.23 | 86.99 | — | — | |
| DeCIProtocol=Five-fold cross-validation, Runs=52026.02 | 89.93 | 80.67 | 79.62 | 79.15 | 88.34 | 83.54 | — | — | |
| ModernTCNProtocol=Five-fold cross-validation, Runs=52026.02 | 85 | 74.99 | 70.62 | 70.35 | 85.46 | 77.28 | — | — | |
| TimesNetProtocol=Five-fold cross-validation, Runs=52026.02 | 82.46 | 61.87 | 64.63 | 61.45 | 87.61 | 71.6 | — | — | |
| LeddamProtocol=Five-fold cross-validation, Runs=52026.02 | 76.96 | 60.81 | 58.16 | 57.36 | 78.68 | 66.39 | — | — | |
| iTransformerProtocol=Five-fold cross-validation, Runs=52026.02 | 75.63 | 60.22 | 55.04 | 54.46 | 72.88 | 63.65 | — | — | |
| DW-DGATValidation Protocol=Ten-fold cross-validation2026.01 | 74.56 | — | — | 70.57 | — | — | 59.31 | 79.66 | |
| SLIM-BrainSamples (K)=4, Evaluation Protocol=Fine-tuning2025.12 | 70.4 | — | — | — | — | — | — | — | |
| NeuroSTORMSamples (K)=58, Evaluation Protocol=Fine-tuning2025.12 | 69.12 | — | — | — | — | — | — | — | |
| SimMVFProtocol=Five-fold cross-validation, Runs=52026.02 | 68.19 | 43.05 | 39.32 | 37.58 | 60.7 | 49.77 | — | — | |
| TimeMixerProtocol=Five-fold cross-validation, Runs=52026.02 | 68.09 | 40.38 | 40.99 | 36.91 | 71.24 | 51.52 | — | — | |
| ChebNetIIValidation Protocol=Ten-fold cross-validation2026.01 | 66.99 | — | — | 58.17 | — | — | 44.01 | 72 | |
| ViT-smallValidation Protocol=Ten-fold cross-validation2026.01 | 66.99 | — | — | 59.54 | — | — | 45.65 | 72.82 | |
| BrainLMSamples (K)=42, Evaluation Protocol=Fine-tuning2025.12 | 66.67 | — | — | — | — | — | — | — | |
| LG-GNNValidation Protocol=Ten-fold cross-validation2026.01 | 66.04 | — | — | 56.92 | — | — | 42.61 | 71.3 | |
| BrainOODProtocol=Five-fold cross-validation, Runs=52026.02 | 65.52 | 36.57 | 31.96 | 29.06 | 64.61 | 45.54 | — | — | |
| GATv2Validation Protocol=Ten-fold cross-validation2026.01 | 65.08 | — | — | 54.79 | — | — | 40.98 | 70.49 | |
| Brain-JEPASamples (K)=32, Evaluation Protocol=Fine-tuning2025.12 | 64.57 | — | — | — | — | — | — | — | |
| PSCRAttnProtocol=Five-fold cross-validation, Runs=52026.02 | 64.52 | 29.66 | 31.79 | 27.51 | 57.22 | 42.14 | — | — | |
| BrainNetCNNEvaluation Protocol=Fine-tuning2025.12 | 64.24 | — | — | — | — | — | — | — | |
| BrainGNNValidation Protocol=Ten-fold cross-validation2026.01 | 64.15 | — | — | 54.83 | — | — | 41.02 | 70.51 | |
| GCNValidation Protocol=Ten-fold cross-validation2026.01 | 63.96 | — | — | 53.6 | — | — | 38.97 | 69.49 | |
| VGG-19-BNValidation Protocol=Ten-fold cross-validation2026.01 | 63.96 | — | — | 53.51 | — | — | 38.61 | 69.31 | |
| TSMixerProtocol=Five-fold cross-validation, Runs=52026.02 | 63.53 | 22.49 | 29.6 | 24.42 | 53.44 | 38.7 | — | — | |
| BrainNet-TValidation Protocol=Ten-fold cross-validation2026.01 | 63.52 | — | — | 53.11 | — | — | 38.1 | 69.05 | |
| BrainMassSamples (K)=65, Evaluation Protocol=Fine-tuning2025.12 | 63.51 | — | — | — | — | — | — | — | |
| BrainNetTFProtocol=Five-fold cross-validation, Runs=52026.02 | 63.31 | 28.22 | 29.28 | 24.91 | 54.83 | 40.11 | — | — | |
| MLPValidation Protocol=Ten-fold cross-validation2026.01 | 63.26 | — | — | 52.78 | — | — | 39.08 | 69.54 | |
| BrainTGLProtocol=Five-fold cross-validation, Runs=52026.02 | 62.97 | 24.66 | 26.73 | 22.11 | 51.05 | 37.5 | — | — | |
| MVHOProtocol=Five-fold cross-validation, Runs=52026.02 | 62.65 | 24.94 | 28.75 | 25.12 | 52.52 | 38.8 | — | — | |
| ResNet-34Validation Protocol=Ten-fold cross-validation2026.01 | 62.57 | — | — | 53.74 | — | — | 39.2 | 69.6 | |
| STAGINProtocol=Five-fold cross-validation, Runs=52026.02 | 61.87 | 16.87 | 25.46 | 19.86 | 50.14 | 34.84 | — | — | |
| BrainNetCNNValidation Protocol=Ten-fold cross-validation2026.01 | 61.79 | — | — | 53.01 | — | — | 37.92 | 68.96 | |
| MDGLProtocol=Five-fold cross-validation, Runs=52026.02 | 61.65 | 16.4 | 25.13 | 19.28 | 48.76 | 34.24 | — | — | |
| GCN-MHSAValidation Protocol=Ten-fold cross-validation2026.01 | 61.54 | — | — | 46.97 | — | — | 33.33 | 66.67 | |
| RA-GCNValidation Protocol=Ten-fold cross-validation2026.01 | 61.54 | — | — | 46.97 | — | — | 33.33 | 66.67 | |
| SVMProtocol=Five-fold cross-validation, Runs=52026.02 | 60.34 | 16.33 | 24.67 | 19.23 | 63.93 | 36.9 | — | — | |
| Random ForestProtocol=Five-fold cross-validation, Runs=52026.02 | 58.13 | 18.61 | 24.55 | 20.25 | 47.51 | 33.81 | — | — | |
| SwiFTSamples (K)=10, Evaluation Protocol=Fine-tuning2025.12 | 58.1 | — | — | — | — | — | — | — | |
| BrainGNNEvaluation Protocol=Fine-tuning2025.12 | 55.56 | — | — | — | — | — | — | — | |
| MA-GCNNValidation Protocol=Ten-fold cross-validation2026.01 | 50.69 | — | — | 44.12 | — | — | 37.5 | 68.75 |